Send your questions in advance (Subject: Symposium Question) to brosenstein@crt.org                                                          (Note: Times are United States Eastern Time)

GENERAL SESSION:

8:50am-9:00am – Welcome and Introduction
Richard T. Silver, MD, Weill Cornell Medicine, New York, NY – Program Chair
Lewis C. Cantley, PhD, Director, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY
David Boule, Patient Committee Chair

9:00am-9:30am – Inflammation in MPNs: Clinical and Therapeutic Aspects
Hans Hasselbalch, MD, PhD, Professor, Department of Hematology,
Roskilde Hospital, Roskilde, Denmark

9:30am-10:00am – Next Generation Sequencing in Diagnosis and Treatment
Joseph M. Scandura, MD, PhD, Associate Professor of Medicine, Weill Cornell Medicine,
New York, NY

10:00am-10:30am – Polycythemia Vera: Interferon Prolongs Myelofibrosis-Free and Overall Survival
Ghaith Abu-Zeinah, MD, Instructor in Medicine, Weill Cornell Medicine, New York, NY

10:30am-10:45am – Break

10:45am-11:15am – Current Management, New Treatments, New Drugs in the Pipeline, and Evolution of Myelofibrosis
Ronald Hoffman, MD, Professor of Medicine, Icahn School of Medicine at Mount Sinai,
New York, NY

11:15am-11:45am – Current Management of Essential Thrombocythemia
Ellen Ritchie, MD, Associate Professor of Medicine, Weill Cornell Medicine, New York, NY

11:45am-12:15pm – Thrombotic, Vascular, and Bleeding Complications in the MPNs
Andrew I. Schafer, MD, Professor of Medicine, Weill Cornell Medicine, New York, NY

12:15pm-12:45pm – Lunch Break

12:45pm-1:30pm – General Q&A Session
Moderator: Richard T. Silver, MD, Professor Emeritus of Medicine, Weill Cornell Medicine,
New York, NY

2:00pm-3:00pm – DISEASE-SPECIFIC Q&A BREAKOUT GROUPS:

Polycythemia Vera:
Drs. Abu-Zeinah and Silver

Essential Thrombocythemia:
Drs. Ritchie and Schafer

Myelofibrosis:
Drs. Hasselbalch, Hoffman and Scandura

3:00pm – Adjournment

Registration required –
REGISTER TODAY

***

Presenting Sponsor-